Ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate
C26H31N3O5 — CID 118857839
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate
Ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate (PubChem CID 118857839) has the molecular formula C26H31N3O5 and a molecular weight of 465.55 g/mol. Its IUPAC name is ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate |
|---|---|
| PubChem CID | 118857839 |
| Molecular Formula | C26H31N3O5 |
| Molecular Weight | 465.55 g/mol |
| Exact Mass | 465.23 |
| IUPAC Name | ethyl (3S,4S)-1-[2-(2,4-dioxo-1H-quinazolin-3-yl)ethyl]-4-[4-(1-hydroxyethyl)phenyl]piperidine-3-carboxylate |
| SMILES | CCOC(=O)[C@@H]1CN(CCn2c(=O)[nH]c3ccccc3c2=O)CC[C@@H]1c1ccc(C(C)O)cc1 |
| InChI | InChI=1S/C26H31N3O5/c1-3-34-25(32)22-16-28(13-12-20(22)19-10-8-18(9-11-19)17(2)30)14-15-29-24(31)21-6-4-5-7-23(21)27-26(29)33/h4-11,17,20,22,30H,3,12-16H2,1-2H3,(H,27,33)/t17?,20-,22-/m1/s1 |
| InChIKey | IPBGFWDFGHJBOU-SXHSKPAUSA-N |
| XLogP | 2.41 |
| TPSA | 104.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.55 |
| LogP ≤ 5 | 2.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118857839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.